Vir Biotechnology (VIR)
(Delayed Data from NSDQ)
$7.26 USD
-0.28 (-3.71%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $7.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Earnings News For VIR
-
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates
-
Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities
-
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q1 Earnings Expected to Decline
-
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Misses Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Vir Biotechnology, Inc. (VIR) Expected to Beat Earnings Estimates: Should You Buy?
-
Vir Biotechnology, Inc. (VIR) Q3 Earnings and Revenues Surpass Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
-
Analysts Estimate Vir Biotechnology, Inc. (VIR) to Report a Decline in Earnings: What to Look Out for
-
Vir Biotechnology, Inc. (VIR) Q1 Earnings and Revenues Beat Estimates
-
Vir Biotechnology, Inc. (VIR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Vir Biotechnology, Inc. (VIR) Q4 Earnings and Revenues Beat Estimates
-
Vir Biotechnology, Inc. (VIR) Reports Next Week: Wall Street Expects Earnings Growth
-
Vir Biotechnology, Inc. (VIR) Beats Q3 Earnings and Revenue Estimates
-
Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release